Sage Therapeutics Rises as Depression Study Moves to Fast Lane

(Bloomberg) -- Sage Therapeutics Inc. climbed the most in two months after the U.S. Food and Drug Administration approved an expedited development plan for what the company says could be a practice...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.